David Rey

2.6k total citations
67 papers, 1.2k citations indexed

About

David Rey is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, David Rey has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 35 papers in Epidemiology and 28 papers in Virology. Recurrent topics in David Rey's work include HIV/AIDS drug development and treatment (30 papers), HIV/AIDS Research and Interventions (29 papers) and HIV Research and Treatment (28 papers). David Rey is often cited by papers focused on HIV/AIDS drug development and treatment (30 papers), HIV/AIDS Research and Interventions (29 papers) and HIV Research and Treatment (28 papers). David Rey collaborates with scholars based in France, Martinique and United States. David Rey's co-authors include Jean-Marie Lang, Marialuisa Partisani, Marie-Josée Wendling, Laurent Cotte, Marie‐Paule Schmitt, Odile Launay, Denis Vetter, Lionel Piroth, Antoine Chéret and P. Meyer and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

David Rey

62 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Rey France 21 741 558 546 305 136 67 1.2k
Anna Maccabruni Italy 16 610 0.8× 340 0.6× 505 0.9× 238 0.8× 116 0.9× 59 1.0k
Patrick Miailhes France 24 995 1.3× 383 0.7× 862 1.6× 134 0.4× 69 0.5× 82 1.4k
Marialuisa Partisani France 15 351 0.5× 598 1.1× 146 0.3× 297 1.0× 391 2.9× 38 1.1k
Marek Nowicki United States 21 1.1k 1.5× 359 0.6× 1.1k 2.1× 224 0.7× 153 1.1× 47 1.7k
Kristen Marks United States 19 676 0.9× 321 0.6× 650 1.2× 65 0.2× 55 0.4× 49 1.1k
Kenrad E. Nelson United States 8 988 1.3× 377 0.7× 885 1.6× 264 0.9× 49 0.4× 8 1.4k
Shanmugam Saravanan India 21 679 0.9× 622 1.1× 452 0.8× 430 1.4× 44 0.3× 114 1.4k
Josep M. Gatell Spain 22 780 1.1× 991 1.8× 360 0.7× 575 1.9× 233 1.7× 61 1.6k
Knud Schewe Germany 19 546 0.7× 867 1.6× 350 0.6× 300 1.0× 219 1.6× 47 1.2k
Maria Franca Pirillo Italy 19 378 0.5× 933 1.7× 127 0.2× 539 1.8× 179 1.3× 58 1.3k

Countries citing papers authored by David Rey

Since Specialization
Citations

This map shows the geographic impact of David Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rey more than expected).

Fields of papers citing papers by David Rey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rey. The network helps show where David Rey may publish in the future.

Co-authorship network of co-authors of David Rey

This figure shows the co-authorship network connecting the top 25 collaborators of David Rey. A scholar is included among the top collaborators of David Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rey. David Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ruch, Yvon, Anne Fuchs, David Rey, et al.. (2024). Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification. Clinical Infectious Diseases. 79(1). 198–201. 6 indexed citations
3.
Cotte, Laurent, Clotilde Allavena, Thomas Huleux, et al.. (2022). High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort. PLoS ONE. 17(5). e0268670–e0268670. 7 indexed citations
4.
Grzelak, Ludivine, Aurélie Velay, Yoann Madec, et al.. (2021). Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. The Journal of Infectious Diseases. 224(6). 983–988. 49 indexed citations
5.
Cuzin, Lise, Romain Palich, Alain Makinson, et al.. (2021). No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy. HIV Medicine. 23(3). 301–306. 1 indexed citations
6.
Carapito, Raphaël, Luzia Mayr, Anne Molitor, et al.. (2020). A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome. Genes and Immunity. 21(4). 263–268. 6 indexed citations
7.
Gantner, Pierre, Laurent Cotte, Clotilde Allavena, et al.. (2019). Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection. PLoS ONE. 14(4). e0215464–e0215464. 18 indexed citations
8.
Hentzien, Maxime, Moustapha Dramé, Cyrille Delpierre, et al.. (2019). HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort. BMJ Open. 9(1). e024841–e024841. 14 indexed citations
9.
Hentzien, Maxime, Cyrille Delpierre, Pascal Puglièse, et al.. (2018). Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score. PLoS ONE. 13(4). e0195725–e0195725. 7 indexed citations
10.
Pradat, Pierre, Thomas Huleux, F. Raffi, et al.. (2018). Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV. AIDS. 32(8). 1077–1082. 38 indexed citations
11.
Cuzin, Lise, Pascal Puglièse, Clotilde Allavena, et al.. (2017). Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study. PLoS ONE. 12(12). e0187517–e0187517. 9 indexed citations
12.
Poizot‐Martin, Isabelle, Clotilde Allavena, Claudine Duvivier, et al.. (2016). CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART. PLoS ONE. 11(11). e0165774–e0165774. 21 indexed citations
13.
Matheron, Sophie, Jacques Gilquin, Juliette Pavie, et al.. (2016). Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France. AIDS. 30(14). 2235–2246. 10 indexed citations
14.
Piroth, Lionel, Anne Marie Taburet, Corine Vincent, et al.. (2015). High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study. Clinical Infectious Diseases. 61(5). 817–825. 10 indexed citations
15.
Rey, David, et al.. (2014). Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART. Infectious Diseases. 47(2). 88–95. 16 indexed citations
16.
Hoën, Bruno, Fabrice Bonnet, Constance Delaugerre, et al.. (2014). French 2013 guidelines for antiretroviral therapy of HIV‐1 infection in adults. Journal of the International AIDS Society. 17(1). 19034–19034. 36 indexed citations
17.
Rey, David. (2011). Post-exposure prophylaxis for HIV infection. Expert Review of Anti-infective Therapy. 9(4). 431–442. 16 indexed citations
18.
Piroth, Lionel, Stanislas Pol, Karine Lacombe, et al.. (2010). Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: The EPIB 2008 study. Journal of Hepatology. 53(6). 1006–1012. 37 indexed citations
19.
Launay, Odile, Sophie Grabar, Emmanuel Gordien, et al.. (2008). Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(3). 272–275. 51 indexed citations
20.
Rey, David, et al.. (1998). HIV-1 Reverse Transcriptase Codon 215 Mutation in Plasma RNA: Immunologic and Virologic Responses to Zidovudine. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(3). 203–208. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Maccabruni Breakdown of academic impact, for papers by Patrick Miailhes Breakdown of academic impact, for papers by Marialuisa Partisani Breakdown of academic impact, for papers by Marek Nowicki Breakdown of academic impact, for papers by Kristen Marks Breakdown of academic impact, for papers by Kenrad E. Nelson Breakdown of academic impact, for papers by Shanmugam Saravanan Breakdown of academic impact, for papers by Josep M. Gatell Breakdown of academic impact, for papers by Knud Schewe Breakdown of academic impact, for papers by Maria Franca Pirillo
Rankless by CCL
2026